The Journal of Organic Chemistry
ARTICLE
[ethyl acetateꢀhexane (1:1)] to afford 22 (0.032 g, 75% from 20) as a
6.17 (1H, dt, J = 10.4, 1.9 Hz), 6.95 (1H, m), 7.14 (1H, dd, J = 7.6, 5.0
colorless solid: mp 93ꢀ95 °C; [R]22 þ1.7 (c 0.80, CHCl3); IR ν
Hz), 7.69 (1H, dd, J = 7.6, 1.6 Hz), 8.38 (1H, dd, J = 5.0, 1.6 Hz); 13
C
D
(neat, cmꢀ1) 3375, 1256, 1099, 835, 775; 1H NMR (400 MHz, CDCl3)
δ 0.03 (6H, s), 0.89 (9H, s), 1.18ꢀ1.41 (2H, m), 1.47ꢀ1.78 (7H, m),
1.80 (1H, br s), 2.08 (1H, ddd, J = 14.2, 11.8, 4.4 Hz), 2.49ꢀ2.62 (1H,
m), 2.86 (1H, dd, J = 16.8, 10.2 Hz), 2.93 (1H, dd, J = 16.8, 8.6 Hz),
3.54ꢀ3.67 (3H, m), 7.05 (1H, dd, J = 7.6, 4.8 Hz), 7.43 (1H, dd, J = 7.6,
1.6 Hz), 8.33 (1H, dd, J = 4.8, 1.6 Hz); 13C NMR (100 MHz, CDCl3) δ
ꢀ5.3, 18.3, 20.1, 22.8, 24.5, 25.9, 27.4, 29.6, 36.6, 40.8, 52.2, 63.5, 72.5,
120.9, 131.5, 142.4, 147.5, 164.3; MS m/z 361 (Mþ, 2.8%), 346 (4.2%),
304 (Mþ ꢀ t-Bu, 100.0%), 212 (39.9%), 170 (25.5%); HRMS calcd for
C21H35O2NSiþ (Mþ) 361.2437, found 361.2432.
NMR (100 MHz, CDCl3) δ ꢀ5.4, 18.3, 25.9, 27.2, 28.1, 33.4, 38.9, 39.7,
58.5, 63.0, 122.0, 130.8, 133.4, 138.3, 148.2, 148.4, 162.7, 198.6; MS m/z
342 (Mþ ꢀ Me, 3.7%), 300 (Mþ ꢀ t-Bu, 100.0%), 232 (14.1%), 20þ8
(28.0%) 182 (14.0%), 180 (8.8%); HRMS calcd for C17H22O2NSi
(Mþ ꢀ t-Bu) 300.1420, found 300.1403.
(4bS,7R,8aS)-4b-[3-(tert-Butyldimethylsilanyloxy)propyl]-
7-methyl-4b,6,7,8,8a,9-hexahydroindeno[2,1-b]pyridin-5-
one (27a)7b. A solution of methyllithium (1.0 M in diethyl ether,
0.738 mL, 0.738 mmol) was added to a suspension of cuprous cyanide
(0.033 g, 0.369 mmol) in anhydrous THF (2.0 mL) at 0 °C, and the
mixture was stirred for 30 min. A solution of 26 (0.033 g, 0.0923 mmol)
in anhydrous THF (1.0 mL) was added at ꢀ40 °C, and the resulting
mixture was stirred for 1 h at the same temperature. Phosphate buffer
solution (pH 6.86) was added to the mixture, and the aqueous phase was
extracted with ethyl acetate. The combined organic solution was dried
over anhydrous sodium sulfate and concentrated. The residue was
purified by silica gel column chromatography [ethyl acetateꢀhexane
(4bS,8aS)-4b-[3-(tert-Butyldimethylsilanyloxy)propyl]-
4b,6,7,8,8a,9-hexahydroindeno[2,1-b]-pyridin-5-one (23).
Sulfur trioxide pyridine complex (0.180 g, 1.13 mmol) and triethyla-
mine (0.229 g, 2.27 mmol) were successively added to a solution of 22
(0.164 g, 0.454 mmol) in anhydrous DMSO (10 mL) at room
temperature, and the mixture was stirred at the same temperature
for 12 h. Water was added to the mixture, and the aqueous phase was
extracted with ethyl acetate. The combined organic solution was dried
over anhydrous sodium sulfate and concentrated. The residue was
purified by silica gel column chromatography [ethyl acetateꢀhexane
(1:3)] to afford 23 (0.148 g, 91%) as a colorless oil: [R]25D þ28.8 (c
(1:4)] to afford 27a (0.027 g, 78%) as a yellow oil: [R]28 þ111.8
D
(c 0.70, MeOH); IR ν (neat, cmꢀ1) 1704, 1424, 1255, 1098, 836, 776;
1H NMR (400 MHz, CDCl3) δ 0.02 (6H, s), 0.88 (9H, s), 1.06 (3H, d,
J = 6.0 Hz), 1.30ꢀ1.41 (1H, m), 1.47ꢀ1.58 (1H, m), 1.72 (1H, ddd, J =
14.4, 10.0, 5.0 Hz), 1.78ꢀ1.90 (2H, m), 1.98 (1H, ddd, J = 14.4, 12.2, 5.0
Hz), 2.05ꢀ2.20 (2H, m), 2.30ꢀ2.41 (1H, m), 2.83 (1H, dd, J = 15.6, 8.8
Hz), 2.85ꢀ2.94 (1H, m), 3.12 (1H, dd, J = 15.6, 7.2 Hz), 3.53ꢀ3.62
(2H, m), 7.11 (1H, dd, J = 7.6, 4.8 Hz), 7.53 (1H, dd, J = 7.6, 1.6 Hz),
8.38 (1H, dd, J = 4.8, 1.6 Hz); 13C NMR (100 MHz, CDCl3) δ ꢀ5.4,
18.3, 21.7, 25.9, 28.0, 28.3, 32.7, 34.4, 38.4, 41.8, 46.9, 61.3, 62.8, 121.5,
133.6, 137.8, 148.6, 163.3, 212.8; 1H NMR (400 MHz, C6D6) δ 0.026
(3H, s), 0.029 (3H, s), 0.60 (3H, d, J = 6.4 Hz), 0.95 (9H, s), 1.19 (1H,
ddd, J = 14.1, 10.1, 5.5 Hz), 1.24ꢀ1.38 (2H, m), 1.38ꢀ1.56 (2H, m),
1.71 (1H, ddd, J = 13.5, 12.5, 4.1 Hz), 1.81 (1H, dd, J = 15.4, 10.2 Hz),
1.91 (1H, ddd, J = 13.4, 12.4, 4.8 Hz), 2.09 (1H, ddd, J = 15.4, 4.5, 0.9
Hz), 2.42ꢀ2.51 (1H, m), 2.66 (1H, dd, J = 16.8, 7.8 Hz), 3.04 (1H, dd,
J = 16.8, 8.4 Hz), 3.36ꢀ3.48 (2H, m), 6.70 (1H, dd, J = 7.8, 4.8 Hz), 7.44
(1H, dd, J = 7.8, 1.4 Hz), 8.43 (1H, dd, J = 4.8, 1.4 Hz); 13C NMR (100
MHz, C6D6) δ ꢀ5.2, 18.4, 21.3, 26.1, 27.5, 28.8, 33.6, 34.7, 39.1, 41.3,
46.8, 61.2, 63.2, 121.5, 133.2, 138.1, 149.3, 164.1, 210.8; MS m/z 358
(Mþ ꢀ Me, 4.2%), 316 (Mþ ꢀ t-Bu, 100.0%), 224 (16.8%), 185 (12.5%);
HRMS calcd forC18H26O2NSi þ (Mþ ꢀ t-Bu) 316.1732, found 316.1715.
(þ)-Lycopladine A [(þ)-(6)]6,7. TBAF (1.0 M solution in THF,
0.217 mL, 0.217 mmol) was added to a solution 27a (0.054 g, 0.145
mmol) in THF (2.0 mL) at room temperature. After stirring for 5.5 h at
the same temperature, phosphate buffer solution (pH 6.86) was added
to the mixture. The aqueous phase was extracted with ethyl acetate and
the combined extract was washed with saturated aqueous sodium
chloride solution, dried over anhydrous sodium sulfate, and concen-
trated. The residue was purified by silica gel column chromatography
[ethyl acetateꢀhexane (1:1) f chloroformꢀmethanol (95:5)] to afford
(þ)-lycopladine A [(þ)-(6)] (0.034 g, 92%) as a colorless solid: mp
153ꢀ155 °C [lit.7b 119ꢀ121 °C for (()-(6)]; [R]27D þ155.5 (c 1.10,
MeOH) [lit. [R]23 þ102 (c 1.0, MeOH),6 [R]23 þ144 (c 0.7,
1
1.24, MeOH); IR ν (neat, cmꢀ1) 1703, 1421, 1256, 1097, 835; H
NMR (600 MHz, C6D6) δ 0.02 (3H, s), 0.03 (3H, s), 0.95 (9H, s),
0.97ꢀ1.07 (1H, m), 1.15ꢀ1.31 (2H, m), 1.32ꢀ1.51 (3H, m), 1.57
(1H, td, J = 12.6, 4.2 Hz), 1.87 (1H, ddd, J = 16.2, 9.3, 6.3 Hz), 1.95
(1H, td, J = 12.6, 4.6 Hz), 2.11 (1H, dt, J = 16.2, 6.0 Hz), 2.33 (1H,
ddd, J = 13.1, 8.2, 4.9 Hz), 2.64 (1H, dd, J = 16.8, 4.2 Hz), 3.11 (1H,
dd, J = 16.8, 7.8 Hz), 3.40 (1H, dt, J = 10.2, 6.6 Hz), 3.46 (1H, dt, J =
10.2, 6.1 Hz), 6.65 (1H, ddd, J = 7.6, 4.8, 0.9 Hz), 7.41 (1H, d, J = 7.6
Hz), 8.40 (1H, d, J = 4.8 Hz); 13C NMR (150 MHz, C6D6) δ ꢀ5.24,
ꢀ5.22, 18.4, 21.5, 26.1, 28.4, 29.3, 34.5, 39.1, 39.5, 42.6, 62.3, 63.3,
121.6, 132.5, 138.2, 149.3, 164.1, 210.4; MS m/z 344 (Mþ ꢀ Me,
8.6%), 302 (Mþ ꢀ t-Bu, 100.0%), 210 (46.6%), 171 (30.0%); HRMS
calcd for C17H24NO2Siþ (Mþ ꢀ t-Bu) 302.1576, found 302.1565.
(4bS,8aS)-4b-[3-(tert-Butyldimethylsilanyloxy)propyl]-
4b,8,8a,9-tetrahydroindeno[2,1-b]-pyridin-5-one (26) (Table 2,
Entry 7). LHMDS (1.0 M solution in THF, 1.0 mL, 1.0 mmol) was
added to a solution of 23 (0.073 g, 0.2030 mmol) in THF (2.8 mL) at
ꢀ78 °C. After stirring for 1 h at ꢀ40 °C, HMPA (0.3 mL) was added
and the mixture was stirred for 30 min. Chlorotrimethylsilane (0.22 g,
2.03 mmol) was added at ꢀ40 °C, and the stirring was continued for a
further 1 h at the same temperature. Triethylamine (0.5 mL) and
phosphate buffer solution (pH 6.86) were added to the mixture, and
the aqueous phase was extracted with hexane. The combined mixture
was dried over potassium carbonate and concentrated to afford the crude
silyl enol ether 25 as a yellow oil, which was used in the next reaction
without further purification.
To a solution of 2-iodoxybenzoic acid (0.227 g, 0.812 mmol) and
4-methoxypyridine N-oxide hydrate (MPO) (0.102 g, 0.812 mmol) in
anhydrous DMSO (0.7 mL) was successively added a solution of the
crude 25 in anhydrous DMSO (0.30 mL) at room temperature, and the
mixture was stirred for 2 days at the same temperature. Water was added
to the mixture, and the aqueous phase was extracted with diethyl ether.
The combined organic solution was washed with saturated aqueous
sodium chloride solution, dried over anhydrous sodium sulfate, and
concentrated. The residue was chromatographed on silica gel [ethyl
acetateꢀhexane (1:3)] to provide 26 (0.058 g, 80% from 23) as a yellow
oil: [R]28D þ149.7 (c 1.46, MeOH); IR ν (neat, cmꢀ1) 1666, 1097; 1H
NMR (400 MHz, CDCl3) δ 0.03 (6H, s), 0.88 (9H, s), 1.43ꢀ1.59 (2H,
m), 1.86 (1H, ddd, J = 13.8, 11.2, 5.1 Hz), 2.11 (1H, ddd, J = 13.8, 11.2,
5.7 Hz), 2.41ꢀ2.54 (1H, m), 2.74 (1H, dquint, J = 18.0, 2.8 Hz),
2.87ꢀ3.07 (2H, m), 3.19 (1H, dd, J = 14.6, 6.6 Hz), 3.51ꢀ3.67 (2H, m),
D
D
MeOH)7a]; IR ν (neat, cmꢀ1) 3363, 1700, 1424; 1H NMR (400
MHz, CD3OD) δ 1.07 (3H, d, J = 6.4 Hz), 1.27ꢀ1.39 (1H, m),
1.49ꢀ1.61 (1H, m), 1.76ꢀ1.91 (3H, m), 2.05 (1H, ddd, J = 13.7, 12.5,
4.7 Hz), 2.09ꢀ2.15 (1H, m), 2.25ꢀ2.30 (2H, m), 2.82 (1H, dd, J = 16.3,
9.0 Hz), 2.88ꢀ2.99 (1H, m), 3.08 (1H, dd, J = 16.3, 8.0 Hz), 3.47ꢀ3.56
(2H, m), 7.23 (1H, dd, J = 8.0, 4.8 Hz), 7.66 (1H, dd, J = 8.0, 1.6 Hz),
8.29 (1H, dd, J = 4.8, 1.6 Hz); 13C NMR (100 MHz, CD3OD) δ 22.0,
29.1, 29.5, 33.4, 34.8, 38.6, 43.4, 47.7, 62.6, 62.8, 123.0, 136.1, 140.0,
148.7, 164.3, 214.5; MS m/z 259 (Mþ, 45.4%), 241 (40.1%), 215
(100.0%), 172 (53.9%), 144 (43.3%), 131 (36.6%), 130 (29.7%);
HRMS calcd for C16H21O2Nþ (Mþ) 259.1572, found 259.1584.
4531
dx.doi.org/10.1021/jo200418y |J. Org. Chem. 2011, 76, 4522–4532